283 related articles for article (PubMed ID: 34708035)
1. Comprehensive Analysis of Hexokinase 2 Immune Infiltrates and m6A Related Genes in Human Esophageal Carcinoma.
Liu XS; Liu JM; Chen YJ; Li FY; Wu RM; Tan F; Zeng DB; Li W; Zhou H; Gao Y; Pei ZJ
Front Cell Dev Biol; 2021; 9():715883. PubMed ID: 34708035
[No Abstract] [Full Text] [Related]
2. Comprehensive Analysis of GLUT1 Immune Infiltrates and ceRNA Network in Human Esophageal Carcinoma.
Liu XS; Gao Y; Wu LB; Wan HB; Yan P; Jin Y; Guo SB; Wang YL; Chen XQ; Zhou LM; Yang JW; Kui XY; Liu XY; Pei ZJ
Front Oncol; 2021; 11():665388. PubMed ID: 34123828
[TBL] [Abstract][Full Text] [Related]
3. High expression of HNRNPR in ESCA combined with
Liu XY; Gao Y; Kui XY; Liu XS; Zhang YH; Zhang Y; Ke CB; Pei ZJ
J Transl Med; 2022 Oct; 20(1):450. PubMed ID: 36195940
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive Analysis of YTHDF1 Immune Infiltrates and ceRNA in Human Esophageal Carcinoma.
Liu XS; Kui XY; Gao Y; Chen XQ; Zeng J; Liu XY; Zhang Y; Zhang YH; Pei ZJ
Front Genet; 2022; 13():835265. PubMed ID: 35401696
[No Abstract] [Full Text] [Related]
5. SLC2A1 is a Diagnostic Biomarker Involved in Immune Infiltration of Colorectal Cancer and Associated With m6A Modification and ceRNA.
Liu XS; Yang JW; Zeng J; Chen XQ; Gao Y; Kui XY; Liu XY; Zhang Y; Zhang YH; Pei ZJ
Front Cell Dev Biol; 2022; 10():853596. PubMed ID: 35399515
[No Abstract] [Full Text] [Related]
6. NPM1 Is a Prognostic Biomarker Involved in Immune Infiltration of Lung Adenocarcinoma and Associated With m6A Modification and Glycolysis.
Liu XS; Zhou LM; Yuan LL; Gao Y; Kui XY; Liu XY; Pei ZJ
Front Immunol; 2021; 12():724741. PubMed ID: 34335635
[TBL] [Abstract][Full Text] [Related]
7. Bridging Integrator 3 (BIN3) Downregulation Predicts a Poor Prognosis in Patients with Esophagus Carcinoma: A Study based on TCGA Data.
Li D; Deng W; Huang G; Xiao X
Comb Chem High Throughput Screen; 2023; 26(11):1974-1989. PubMed ID: 36475339
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of METTL3 associated with the metabolic status on
Liu XS; Yuan LL; Gao Y; Zhou LM; Yang JW; Pei ZJ
J Cancer; 2020; 11(16):4851-4860. PubMed ID: 32626532
[No Abstract] [Full Text] [Related]
9. Functional enrichment analysis reveals the involvement of DARS2 in multiple biological pathways and its potential as a therapeutic target in esophageal carcinoma.
Liu XS; Liu ZY; Zeng DB; Hu J; Chen XL; Gu JL; Gao Y; Pei ZJ
Aging (Albany NY); 2024 Feb; 16(4):3934-3954. PubMed ID: 38382106
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive Analysis of SLC17A9 and Its Prognostic Value in Hepatocellular Carcinoma.
Kui XY; Gao Y; Liu XS; Zeng J; Yang JW; Zhou LM; Liu XY; Zhang Y; Zhang YH; Pei ZJ
Front Oncol; 2022; 12():809847. PubMed ID: 35957868
[TBL] [Abstract][Full Text] [Related]
11. Identification and validation of necroptosis-related prognostic gene signature and tumor immune microenvironment infiltration characterization in esophageal carcinoma.
Sun K; Hong JJ; Chen DM; Luo ZX; Li JZ
BMC Gastroenterol; 2022 Jul; 22(1):344. PubMed ID: 35840882
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive analysis of m6A RNA methylation regulators in esophageal carcinoma.
Yang H; Liu J; Li L; Wang X; Li Z
Transl Cancer Res; 2024 Jan; 13(1):381-393. PubMed ID: 38410211
[TBL] [Abstract][Full Text] [Related]
13. Identification of clinical prognostic features of esophageal cancer based on m6A regulators.
Wang H; Zhang Y; Chen L; Liu Y; Xu C; Jiang D; Song Q; Wang H; Wang L; Lin Y; Chen Y; Chen J; Xu Y; Hou Y
Front Immunol; 2022; 13():950365. PubMed ID: 36159855
[TBL] [Abstract][Full Text] [Related]
14. Screening and verification of potential gene targets in esophageal carcinoma by bioinformatics analysis and immunohistochemistry.
Wen P; Dayyani F; Tao R; Zhong X
Ann Transl Med; 2022 Jan; 10(2):70. PubMed ID: 35282073
[TBL] [Abstract][Full Text] [Related]
15. Identification and Validation of Chromobox Family Members as Potential Prognostic Biomarkers and Therapeutic Targets for Human Esophageal Cancer.
Fang X; Wang J; Chen J; Zhuang M; Huang T; Chen Z; Huang Y; Zheng B; Wang X
Front Genet; 2022; 13():851390. PubMed ID: 35464847
[No Abstract] [Full Text] [Related]
16. Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma.
Guo W; Tan F; Huai Q; Wang Z; Shao F; Zhang G; Yang Z; Li R; Xue Q; Gao S; He J
Front Immunol; 2021; 12():669750. PubMed ID: 34054840
[TBL] [Abstract][Full Text] [Related]
17. Nucleophosmin 1 is a prognostic marker of gastrointestinal cancer and is associated with m6A and cuproptosis.
Liu XS; Liu C; Zeng J; Zeng DB; Chen YJ; Tan F; Gao Y; Liu XY; Zhang Y; Zhang YH; Pei ZJ
Front Pharmacol; 2022; 13():1010879. PubMed ID: 36188614
[No Abstract] [Full Text] [Related]
18. High expression of caspase-8 as a predictive factor of poor prognosis in patients with esophageal cancer.
Chai J; Lei Y; Xiang X; Ye J; Zhao H; Yi L
Cancer Med; 2023 Mar; 12(6):7651-7666. PubMed ID: 36533709
[TBL] [Abstract][Full Text] [Related]
19. Integrated Analysis of Hub Genes and Pathways In Esophageal Carcinoma Based on NCBI's Gene Expression Omnibus (GEO) Database: A Bioinformatics Analysis.
Yu-Jing T; Wen-Jing T; Biao T
Med Sci Monit; 2020 Aug; 26():e923934. PubMed ID: 32756534
[TBL] [Abstract][Full Text] [Related]
20. m6A reading protein RBMX as a biomarker for prognosis and tumor progression in esophageal cancer.
Tuersun H; Liu L; Zhang J; Maimaitizunong R; Tang X; Li H
Transl Cancer Res; 2023 Sep; 12(9):2319-2335. PubMed ID: 37859733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
